Russia has agreed to produce it’s Sputnik V COVID-19 vaccine in Italy.
The deal was signed on Monday and will combine the efforts of the Italian subsidiary of Adienne Srl and CEO of the Russian Direct Investment Fund Kirill Dmitriev, according to the Italian Russian Chamber of Commerce Tuesday.
“The innovative production process will help create new jobs and allow Italy to control the entire production of the compound,” the chamber said in a statement.
Production of the vaccine is scheduled to begin in July and is expected to produce 10 million doses this year.
Authorities in Russia are working on 20 more collaborations in Europe and the Sputnik V vaccine has been registered in 45 nations according to the group.